Pulmonary Complications
36
3
3
20
Key Insights
Highlights
Success Rate
87% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
8.3%
3 terminated out of 36 trials
87.0%
+0.5% vs benchmark
17%
6 trials in Phase 3/4
20%
4 of 20 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 20 completed trials
Clinical Trials (36)
Low-Flow Anesthesia and Perioperative Atelectasis in Laparoscopic Bariatric Surgery
Association of Different Tidal Volumes and Postoperative Pulmonary Complications
Generative AI Impact on Rheumatoid Arthritis Complications Diagnosis
Effectiveness of an Innovative Chest Stabilizer in Rib Fracture Treatment: Impact on Respiratory Function, Complications, and Clinical Outcomes
The Incidence of Pulmonary, Cardiovascular and Renal System Non-communicable Complications Associated With the Post-acute Phase of the Infection by Covid-19
Prevention of Pulmonary Complications After Laparoscopic Liver Surgery
Effects of Acupressure on Physiological Indicators, Oxygen Demand and Length of Hospital Stay in Premature Infants With Pulmonary Infiltration
Biphasic Positive Airway Pressure Ventilation Versus Flow-Controlled Ventilation in Burn Patients
Hemodynamic Responses to Ventilator Hyperinflation Technique
Evaluation of The MetaNeb® System to Reduce Postoperative Pulmonary Complications
Prevention of Postoperative Events Following Reversal With Sugammadex or Neostigmine
Comparison of BiPAP and ٰIS in Reducing Post CABG Pulmonary Complications
Protective Mechanical VENTilation Strategy in Patients Undergoing CARDiac Surgery
Theophylline in Treating Cancer Patients With Shortness of Breath
Radiation Therapy to Relieve Symptoms in Patients With Non-small Cell Lung Cancer
Intraoperative PEEP Optimization: Effects on Postoperative Pulmonary Complications and Inflammatory Response
Captopril in Treating Patients With Non-Small Cell Lung Cancer or Limited-Stage Small Cell Lung Cancer That Has Been Previously Treated With Radiation Therapy With or Without Chemotherapy
Etanercept in Treating Young Patients With Idiopathic Pneumonia Syndrome After Undergoing a Donor Stem Cell Transplant
Lung Rehabilitation in Treating Patients With Chronic Obstructive Pulmonary Disease Who Are Undergoing Surgery for Lung Cancer
Losartan in Treating Pulmonary Fibrosis in Patients With Stage I, II, or III Non-Small Cell Lung Cancer